Search

everythinglearnresearchcommunity

for

Search:↓

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

Women with PCOS have more emotional and body image issues than healthy women.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

Red clover extract improved hair, skin, mood, sleep, and tiredness in postmenopausal women.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Valproate is a mood stabilizer for bipolar disorder but has side effects and risks, especially during pregnancy.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.